Suffer from Parkinson’s-related LID?
Learn more about a clinical trial for levodopa-induced dyskinesia.
Right now, the gLIDe clinical research study is enrolling adults with Parkinson’s Disease who have levodopa-induced dyskinesia (involuntary movements). Researchers are testing an investigational drug to learn whether it may relieve this effect in these patients.
People who volunteer and qualify for this study will participate for up to 19 weeks. Your health is very important to us and will be monitored throughout the entire study.
If you are interested in participating in our Parkinson’s Disease w/ Involuntary Movements study, please fill out the form below.
You may qualify to participate in this study if you:
- Are aged 30 to 85 years old
- Have been diagnosed with Parkinson’s Disease (PD)
- Take levodopa at least 3 times/day
- Suffer from levodopa-induced dyskinesia (LID)